View Older Stories View More Recent Stories

Feb 27, 2019 04:05PM Pfenex to Participate at Two Investor Conferences in March
Feb 25, 2019 04:05PM Pfenex to Host Conference Call and Webcast Reporting Fourth Quarter Financial Results on Monday, March 11th
Feb 19, 2019 08:11AM Pfenex (PFNX) Announces FDA Acceptance of NDA for PF708
Feb 19, 2019 08:05AM Pfenex Announces FDA Acceptance of NDA for PF708
Dec 10, 2018 08:06AM Pfenex (PFNX) Submits NDA to U.S. FDA Seeking Approval of PF708 for Treatment of Osteoporosis
Dec 10, 2018 08:00AM Pfenex Submits New Drug Application to U.S. FDA Seeking Approval of PF708 for the Treatment of Osteoporosis
Nov 7, 2018 04:05PM Pfenex Reports Third Quarter Results and Provides Business Update
Oct 25, 2018 04:05PM Pfenex to Host Conference Call and Webcast Reporting Third Quarter Financial Results on Wednesday, November 7
Oct 1, 2018 04:05PM Pfenex Reports New Employment Inducement Award Under NYSE American Listing Rules
Sep 21, 2018 04:29PM Pfenex to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
Sep 11, 2018 08:00AM Pfenex Names Dr. Shawn A. Scranton as Sr. Vice President and Chief Operating Officer
Sep 4, 2018 08:00AM Pfenex to Present at the Liolios 7th Annual Gateway Conference
Aug 16, 2018 04:05PM Pfenex Announces Departure of Chief Medical and Scientific Officer Dr. Hubert Chen
Aug 8, 2018 04:05PM Pfenex Reports Second Quarter Results and Provides Business Update
Aug 6, 2018 12:32PM Liolios 7th Annual Gateway Conference to Showcase 100 Leading Companies at the Four Seasons San Francisco September 5-6, 2018
Jul 25, 2018 04:05PM Pfenex to Host Conference Call and Webcast Reporting Second Quarter Financial Results on Wednesday, August 8
Jul 12, 2018 08:13AM Pfenex (PFNX) Secures Milestone Payment from Merck (MRK) for Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114)
Jul 12, 2018 08:00AM Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114)
Jun 22, 2018 05:00PM Pfenex Set to Join Russell 2000® Index
Jun 14, 2018 04:15PM Pfenex to Present at the JMP Securities 2018 Life Science Conference
Jun 12, 2018 09:26AM Pre-Open Movers 06/12: (GLMD) (RH) (PLAY) Higher; (IDRA) (JCAP) (IMMU) Lower (more...)
Jun 11, 2018 04:58PM Pfenex (PFNX), Alvogen Enter U.S. Agreement for Commercialization of PF708
Jun 11, 2018 04:05PM Pfenex and Alvogen Enter into U.S. Agreement for Commercialization of PF708, a Therapeutic Equivalent Candidate to Forteo®
May 30, 2018 09:10AM Pfenex to Present at the Jefferies 2018 Global Healthcare Conference
May 14, 2018 04:05PM Pfenex (PFNX) Reports Positive Top-Line PF708 Study Results in Osteoporosis Patients; On-Track for Submission of NDA in Q3
May 14, 2018 04:02PM Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018
May 10, 2018 04:02PM Pfenex Reports First Quarter 2018 Results and Provides Business Update
Apr 30, 2018 04:15PM Pfenex to Report First Quarter 2018 Results and Provide Business Update on Thursday, May 10th
Apr 18, 2018 05:01PM Pfenex (PFNX) Reports Development & License Agreement with NT Pharma Group for PF708 Therapeutic Equivalent Candidate to Forteo
Apr 18, 2018 05:00PM Pfenex and NT Pharma Enter into a Development and License Agreement for Pfenex's PF708 Therapeutic Equivalent Candidate to Forteo®
Mar 15, 2018 04:02PM Pfenex Reports Fourth Quarter and Full Year 2017 Results and Provides Business Update
Mar 13, 2018 04:15PM Pfenex Inc. to Present at Oppenheimer's 28th Annual Healthcare Conference
Mar 8, 2018 04:15PM Pfenex to Report Fourth Quarter and Full Year 2017 Results and Provide Business Update on Thursday, March 15, 2018
Feb 27, 2018 04:15PM Pfenex Inc. to Present at Barclay's 2018 Global Healthcare Conference
Jan 4, 2018 08:11AM Pfenex (PFNX) Appoints Susan Knudson as CFO
Jan 4, 2018 08:00AM Pfenex Names Susan A. Knudson as Chief Financial Officer
Dec 19, 2017 08:00AM Pfenex earns $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals
Nov 9, 2017 06:15PM Pfenex Inc. to Present at the Jefferies 2017 London Healthcare Conference
Nov 9, 2017 04:05PM Pfenex Reports Third Quarter 2017 Results, Interim PK data from PF708 Study, Completion of Process Development Milestone on Jazz Program and Provides Business Update
Oct 30, 2017 04:05PM Pfenex to Report Third Quarter 2017 Results and Provide Business Update on Thursday, November 9, 2017
Sep 19, 2017 07:00AM Pfenex To Present at the Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017
Sep 1, 2017 07:00AM Pfenex Reports New Employment Inducement Award Under NYSE MKT Listing Rules
Aug 29, 2017 06:00AM Pfenex To Present at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12th, 2017
Aug 23, 2017 08:00AM Pfenex To Present at the 6th Annual Liolios Gateway Conference on September 6th, 2017
Aug 9, 2017 04:05PM Pfenex Reports Second Quarter 2017 Results and Provides Business Update
Aug 3, 2017 06:19AM Pfenex (PFNX) Names Eef Schimmelpennink as CEO
Aug 3, 2017 06:00AM Pfenex Names Eef Schimmelpennink Chief Executive Officer
Jul 25, 2017 05:00PM Pfenex To Report Second Quarter 2017 Results and Provide Business Update on Wednesday, August 9, 2017
May 8, 2017 04:05PM Pfenex Reports First Quarter 2017 Results and Provides Business Update
Apr 24, 2017 08:00AM Pfenex To Report First Quarter 2017 Results and Provide Business Update on Monday, May 8, 2017
View More Recent Stories View Older Stories